CN110669051A - Compound, display panel and display device - Google Patents

Compound, display panel and display device Download PDF

Info

Publication number
CN110669051A
CN110669051A CN201910939930.6A CN201910939930A CN110669051A CN 110669051 A CN110669051 A CN 110669051A CN 201910939930 A CN201910939930 A CN 201910939930A CN 110669051 A CN110669051 A CN 110669051A
Authority
CN
China
Prior art keywords
formula
group
substituent
compound
containing substituent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910939930.6A
Other languages
Chinese (zh)
Inventor
肖文静
高威
代文朋
张磊
牛晶华
安平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianma Microelectronics Co Ltd
Shanghai Tianma AM OLED Co Ltd
Original Assignee
Shanghai Tianma AM OLED Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Tianma AM OLED Co Ltd filed Critical Shanghai Tianma AM OLED Co Ltd
Priority to CN201910939930.6A priority Critical patent/CN110669051A/en
Publication of CN110669051A publication Critical patent/CN110669051A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6576Polycyclic condensed heteroaromatic hydrocarbons comprising only sulfur in the heteroaromatic polycondensed ring system, e.g. benzothiophene
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1007Non-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms

Abstract

The present invention relates to the field of OLED technology and provides a compound having TADF properties, which has a structure of formula (1): a. the1And A2Represents an electron-accepting group such as a hydrogen atom, a phosphorus-oxygen-containing substituent, a sulfone substituent, an aryl boron substituent or the like; l is1And L2Each independently selected from the group consisting of a single bond, phenylene, thienylene, naphthylene, anthracenylene, phenanthrenylene, pyrenylene; ar (Ar)1And Ar2Each independently selected from hydrogen atom, phenyl, thienyl, naphthyl, anthryl, phenanthryl, pyrenyl, phosphorus-oxygen-containing substituent, sulfone substituent, aryl boron substituent and the like. The condensed carbazole structure of the compound has strong electron donating capability and thermal stability. When the condensed carbazole structure acts as an electron donorWhen the bipolar main body material formed by combining the body with a proper acceptor material is applied to the light-emitting layer, good energy transfer can be realized between the bipolar main body material and the doping body, so that the light-emitting efficiency of the device is improved.

Description

Compound, display panel and display device
Technical Field
The invention relates to the technical field of organic electroluminescent materials, in particular to a compound with TADF (TADF) property, a display panel comprising the compound and a display device comprising the compound.
Background
With the development of electronic display technology, Organic Light Emitting Devices (OLEDs) are widely used in various display devices, and research and application of light emitting materials of the OLEDs are increasing.
The materials used for the light-emitting layer of an OLED mainly include the following four types according to the light-emitting mechanism:
(1) a fluorescent material; (2) a phosphorescent material; (3) triplet-triplet annihilation (TTA) material 0; (4) thermally Activated Delayed Fluorescence (TADF) material.
For fluorescent materials, the ratio of singlet to triplet excitons in excitons is 1:3 based on spin statistics, so that the maximum internal quantum yield of the fluorescent material does not exceed 25%. According to the lambertian emission mode, the light extraction efficiency is around 20%, so the External Quantum Effect (EQE) of the OLED based on fluorescent materials does not exceed 5%.
For the phosphorescent material, the phosphorescent material can enhance the intersystem crossing inside molecules through the spin coupling effect due to the heavy atom effect, and can directly utilize 75% of triplet excitons, so that the emission with the participation of S1 and T1 together at room temperature is realized, and the theoretical maximum internal quantum yield can reach 100%. According to the lambertian emission pattern, the light extraction efficiency is about 20%, so that the external quantum effect of OLEDs based on phosphorescent materials can reach 20%. However, the phosphorescent material is basically a heavy metal complex such as Ir, Pt, Os, Re, Ru and the like, and the production cost is high, so that the large-scale production is not facilitated. Under high current density, the phosphorescent material has serious efficiency roll-off phenomenon, and the stability of the phosphorescent device is not good.
For triplet-triplet annihilation (TTA) materials, two adjacent triplet excitons recombine to generate a higher energy singlet excited state molecule and a ground state molecule, but two triplet excitons generate a singlet exciton, so the theoretical maximum internal quantum yield can only reach 62.5%. In order to prevent the generation of the large efficiency roll-off phenomenon, the concentration of triplet excitons needs to be regulated during this process.
For a Thermally Activated Delayed Fluorescence (TADF) material, when the difference between the singlet excited state and the triplet excited state is small, reverse intersystem crossing (RISC) occurs inside the molecule, T1 state excitons are up-converted to S1 state by absorbing environmental heat, 75% of triplet excitons and 25% of singlet excitons can be simultaneously utilized, and the theoretical maximum internal quantum yield can reach 100%. The TADF material is mainly an organic compound, does not need rare metal elements and has low production cost. TADF materials can be chemically modified by a variety of methods. However, the TADF materials found so far are relatively few, and therefore, there is a need to develop new TADF materials that can be used in OLEDs.
Disclosure of Invention
In view of the above, the present invention provides a compound having a Thermally Activated Delayed Fluorescence (TADF) property, the compound having a structure represented by formula (1):
Figure BDA0002222601640000021
A1and A2Represents an electron-accepting group, and A1And A2Each independently selected from hydrogen atom, carbonyl group-containing substituent, imide substituent, phosphorus-oxygen-containing substituent, fluorine-containing substituent, sulfone substituent, aryl boron substituent and cyanogen-containing substituent;
L1and L2Each independently selected from the group consisting of a single bond, phenylene, thienylene, naphthylene, anthracenylene, phenanthrenylene, pyrenylene;
Ar1and Ar2Each independently selected from hydrogen atom, phenyl, thienyl, naphthyl, anthryl, phenanthryl, pyrenyl, carbonyl-containing substituent, imide substituent, phosphorus-oxygen-containing substituent, fluorine-containing substituent, sulfone substituent, aryl boron substituent and cyano-containing substituentA substituent group.
The structure of the condensed carbazole is similar to that of carbazole, and has strong electron donating capability and thermal stability. In addition, because the benzene rings are fused with two five-membered rings containing nitrogen atoms, a certain dihedral angle is formed between the two benzene rings of the fused carbazole, and the non-planar structure inhibits luminescence quenching caused by intermolecular stacking. On the other hand, under the action of condensed rings, the condensed carbazole core controls the torsion angle in a small range, namely certain 'planarity' is maintained, and the structure is favorable for intermolecular charge transfer and improves the carrier mobility of the whole molecule. Therefore, when the fused carbazole is used as a donor and combined with a proper acceptor material to form a bipolar host material to be applied to a light-emitting layer, good energy transfer can be realized between the bipolar host material and a dopant, so that the light-emitting efficiency of the device is improved.
Drawings
FIG. 1 is a general structure of a compound provided by an embodiment of the present invention;
FIG. 2 is a schematic structural diagram of an OLED provided in an embodiment of the present invention;
fig. 3 is a schematic diagram of a display device according to an embodiment of the present invention.
Detailed Description
The present invention is further illustrated by the following examples and comparative examples, which are intended to be illustrative only and are not to be construed as limiting the invention.
One aspect of the present invention provides a compound having a structure represented by formula (1):
Figure BDA0002222601640000031
A1and A2Represents an electron-accepting group, and A1And A2Each independently selected from hydrogen atom, carbonyl group-containing substituent, imide substituent, phosphorus-oxygen-containing substituent, fluorine-containing substituent, sulfone substituent, aryl boron substituent and cyanogen-containing substituent;
L1and L2Each independently selected from the group consisting of a single bond, phenylene, thienylene, naphthylene, anthracenylene, phenanthrenylene, pyrenylene;
Ar1and Ar2Each independently selected from hydrogen atom, phenyl, thienyl, naphthyl, anthryl, phenanthryl, pyrenyl, carbonyl-containing substituent, imide substituent, phosphorus-oxygen-containing substituent, fluorine-containing substituent, sulfone substituent, aryl boron substituent and cyanogen-containing substituent.
According to one embodiment of the compounds of the invention, L1And L2Selected from phenylene.
According to one embodiment of the compounds of the invention, Ar1And Ar2Selected from hydrogen atoms.
According to one embodiment of the compounds of the invention, L1And L2Is phenylene, A1And A2Is a hydrogen atom.
According to one embodiment of the compounds of the invention, L1And L2Selected from the same group, A1And A2Are selected from the same group, and Ar1And Ar2Selected from the same group.
According to one embodiment of the compounds of the invention, L1And L2Selected from phenylene, Ar1And Ar2Each independently selected from carbonyl group-containing substituent, imide substituent, phosphorus-containing oxygen substituent, fluorine-containing substituent, sulfone substituent, aryl boron substituent and cyanogen-containing substituent.
According to one embodiment of the compound of the present invention, the compound has any one of the structures represented by formula (2), formula (3) and formula (4):
Figure BDA0002222601640000041
wherein Ar is1、Ar2And Ar3Are respectively selected from one of phosphorus-oxygen-containing substituent groups, sulfone substituent groups and aryl boron substituent groups.
According to one embodiment of the compound of the present invention, the carbonyl-containing substituent is selected from one of the following groups:
wherein # represents a position capable of linking to formula (1), formula (2), formula (3) or formula (4), and R represents a C1-C20 alkyl group, a C1-C20 alkoxy group, a C2-C20 alkenyl group, a C2-C20 alkynyl group, a C4-C8 cycloalkyl group, a C6-C40 aryl group, a C4-C40 heteroaryl group.
According to one embodiment of the compound of the present invention, the imide-based substituent is selected from one of the following groups:
Figure BDA0002222601640000052
wherein # represents a position capable of linking to formula (1), formula (2), formula (3) or formula (4), and R represents a C1-C20 alkyl group, a C1-C20 alkoxy group, a C2-C20 alkenyl group, a C2-C20 alkynyl group, a C4-C8 cycloalkyl group, a C6-C40 aryl group, a C4-C40 heteroaryl group.
According to one embodiment of the compound of the present invention, the phosphorus-containing oxy substituent is selected from one of the following groups:
x is selected from O, S, -BR41、-C(R41)2、-Si(R41)2and-NR41Any one of the above;
R30、R31、R32、R33、R34、R35、R36、R37、R38、R39、R40、R41each independently selected from a hydrogen atom, a substituted or unsubstituted C1-C20 alkyl group, a substituted or unsubstituted C3-C20 cycloalkyl group, a substituted or unsubstituted C1-C20 alkoxy group, a substituted or unsubstituted C3-C20 heterocyclic group, a substituted or unsubstituted C6-C40 aryl group, a substituted or unsubstituted C2 alkyl group-any one of C40 heteroaryl;
# represents a position at which the compound represented by formula (1), formula (2), formula (3) or formula (4) can be linked.
According to one embodiment of the compound of the present invention, the fluorine-containing substituent is selected from one of the following groups:
Figure BDA0002222601640000062
# represents a position at which the compound represented by formula (1), formula (2), formula (3) or formula (4) can be linked.
According to an embodiment of the compound of the present invention, the sulfone substituent is selected from one of the following groups:
Figure BDA0002222601640000063
# represents a position at which the compound represented by formula (1), formula (2), formula (3) or formula (4) can be linked.
According to one embodiment of the compound of the present invention, the aryl boron type substituent is selected from one of the following groups:
Figure BDA0002222601640000071
R15-R23each independently selected from alkyl, alkoxy, phenyl, aryl or heteroaryl; x1Selected from the group consisting of boron, oxygen, sulfur, nitrogen, when X1When it is an oxygen atom or a sulfur atom, R23Is absent;
# represents the position to which formula (1), formula (2), formula (3) or formula (4) is linked.
According to one embodiment of the compound of the present invention, the aryl boron type substituent is selected from one of the following groups:
# represents a position at which the compound represented by formula (1), formula (2), formula (3) or formula (4) can be linked.
According to one embodiment of the compound of the present invention, the cyano-containing substituent is selected from one of the following groups:
Figure BDA0002222601640000073
wherein # represents a position at which formula (1), (2), (3) or (4) can be linked. .
According to one embodiment of the compound of the present invention, the compound is selected from the following compounds:
Figure BDA0002222601640000081
Figure BDA0002222601640000091
Figure BDA0002222601640000101
Figure BDA0002222601640000111
according to one embodiment of the compounds of the present invention, the energy level difference Δ E between the lowest singlet energy level S1 and the lowest triplet energy level T1 of the compoundST=ES1-ET1≦0.30eV。
The compound has TADF (thermo-activated functional) characteristics, and can be used as a host material or a guest material of an OLED light-emitting layer.
The present invention also provides methods for preparing exemplary compounds P1, P2, P4, P5, P13, P14, P16, P17, P22, P27, P30, P31, P32, P33, as described in exemplary synthetic examples 1 to 14 below.
Example 1
Synthesis of Compound P1
Figure BDA0002222601640000112
S2(1mmol) and S18(2mmol) were dissolved in toluene solvent under nitrogen blanket, and Pd (PPh) was added3)4And refluxing for 6h at 120 ℃. After the reaction was completed, it was cooled to room temperature, and the crude product was collected. The crude product was purified by silica gel chromatography using a mixed solvent of n-hexane and chloroform (5:1) as an eluent to finally purify P1(0.88mmol, 88%) as a solid.
MALDI-TOF MS:C48H30B2N2O2Calculated m/z: 688.39, respectively; measurement values: 688.25.
elemental analysis results: c, 83.75; h, 4.39; b, 3.14; n, 4.07; o, 4.65; measurement values: c, 83.65; h, 4.49; b, 3.24; n, 4.05; and O, 4.57.
Example 2
Synthesis of Compound P2
Figure BDA0002222601640000121
S1(1mmol) was dissolved in o-dichlorobenzene as solvent under nitrogen protection, PPh was added3Heating to reflux, and reacting for 8 h. After the reaction was completed, the reaction mixture was cooled to room temperature, and all the solvent was removed by distillation under the reduced pressure to collect a crude product. The crude product was purified by silica gel chromatography using a mixed solvent of n-hexane: chloroform (5:1) as an eluent to finally purify S2(0.92mmol, 92%) as a solid.
MALDI-TOF MS:C12H8N2Calculated m/z: 180.21, respectively; measurement values: 180.07.
Figure BDA0002222601640000122
s2(1mmol) and S3(2mmol) were dissolved in toluene solvent under nitrogen blanket, and Pd (PPh) was added3)4And refluxing for 6h at 120 ℃. After the reaction was completed, it was cooled to room temperature, and the crude product was collected. Purifying the crude product with silica gel chromatography column using n-hexaneChloroform (5:1) as eluent, and finally purified to obtain P2(0.88mmol, 88%) as a solid.
MALDI-TOF MS:C48H34N2O2P2Calculated m/z: 732.74, respectively; measurement values: 732.21.
elemental analysis results: c, 78.68; h, 4.68; n, 3.82; o, 4.37; p, 8.45; measurement values: c, 78.66; h, 4.71; n, 3.80; o, 4.39; p, 8.44.
Example 3
Synthesis of Compound P4
Figure BDA0002222601640000131
S2(1mmol) and S19(2mmol) were dissolved in toluene solvent under nitrogen blanket, and Pd (PPh) was added3)4And refluxing for 6h at 120 ℃. After the reaction was completed, it was cooled to room temperature, and the crude product was collected. The crude product was purified by silica gel chromatography using a mixed solvent of n-hexane and chloroform (5:1) as an eluent to finally purify P4(0.88mmol, 88%) as a solid.
MALDI-TOF MS:C48H28N2O4S2Calculated m/z: 760.88, respectively; measurement values: 760.15.
elemental analysis results: c, 75.77; h, 3.71; n, 3.68; o, 8.41; s, 8.43; measurement values: c, 75.67; h, 3.76; n, 3.71; o, 8.37; s, 8.49.
Example 4
Synthesis of Compound P5
S2(1mmol) and S20(2mmol) were dissolved in toluene solvent under nitrogen blanket, and Pd (PPh) was added3)4And refluxing for 6h at 120 ℃. After the reaction was completed, it was cooled to room temperature, and the crude product was collected. The crude product was purified by silica gel chromatography using a mixed solvent of n-hexane and chloroform (5:1) as an eluent to obtain P5(0.88mmol, 88%)。
MALDI-TOF MS:C40H20N6Calculated m/z: 584.63, respectively; measurement values: 584.17.
elemental analysis results: c, 82.18; h, 3.45; n, 14.38; measurement values: c, 82.25; h, 3.55; n, 14.20.
Example 5
Synthesis of Compound P13
Figure BDA0002222601640000142
S4(1mmol) was dissolved in o-dichlorobenzene solvent under nitrogen protection, PPh3 was added, heated to reflux, and reacted for 8 h. After the reaction was completed, the reaction mixture was cooled to room temperature, and all the solvent was removed by distillation under the reduced pressure to collect a crude product. The crude product was purified by silica gel chromatography using a mixed solvent of n-hexane: chloroform (5:1) as an eluent to finally purify S5(0.92mmol, 92%) as a solid.
MALDI-TOF MS:C18H24N2Si2Calculated m/z: 324.57, respectively; measurement values: 324.15.
Figure BDA0002222601640000151
s5(1mmol) and S6(2mmol) were dissolved in toluene solvent under nitrogen blanket, and Pd (PPh) was added3)4And refluxing for 6h at 120 ℃. After the reaction was completed, it was cooled to room temperature, and the crude product was collected. The crude product was purified by silica gel chromatography using a mixed solvent of n-hexane: chloroform (5:1) as an eluent to finally purify S7(0.88mmol, 88%) as a solid.
MALDI-TOF MS:C30H32N2Si2Calculated m/z: 476.76, respectively; measurement values: 476.21.
Figure BDA0002222601640000152
s7(1mmol) and NBS (3mmol) were dissolved in dichloromethane under nitrogen and stirred at room temperature for 12 h. After the reaction was completed, all the solvent was distilled off under reduced pressure, and the crude product was collected. The crude product was purified by silica gel chromatography using a mixed solvent of n-hexane and chloroform (5:1) as an eluent to finally purify S8(0.97mmol, 97%) as a solid.
MALDI-TOF MS:C24H14Br2N2Calculated m/z: 490.19, respectively; measurement values: 489.95.
Figure BDA0002222601640000153
s8(1mmol) and S9(2mmol) were dissolved in toluene solvent under nitrogen blanket, and Pd (PPh) was added3)4And refluxing for 6h at 120 ℃. After the reaction was completed, it was cooled to room temperature, and the crude product was collected. The crude product was purified by silica gel chromatography using a mixed solvent of n-hexane and chloroform (5:1) as an eluent to finally purify P13(0.88mmol, 88%) as a solid.
MALDI-TOF MS:C48H26N4O4Calculated m/z: 722.74, respectively; measurement values: 722.20.
elemental analysis results: c, 79.77; h, 3.63; n, 7.75; o, 8.85; measurement values: c, 79.12; h, 3.59; n, 7.63; and O, 9.66.
Example 6
Synthesis of Compound P14
Figure BDA0002222601640000161
S8(1mmol) and S21(2mmol) were dissolved in toluene solvent under nitrogen blanket, and Pd (PPh) was added3)4And refluxing for 6h at 120 ℃. After the reaction was completed, it was cooled to room temperature, and the crude product was collected. The crude product was purified by silica gel chromatography using a mixed solvent of n-hexane and chloroform (5:1) as an eluent to finally purify P14(0.88mmol, 88%) as a solid.
MALDI-TOF MS:C60H42N2O2P2Calculated m/z: 884.94, respectively; measuringMagnitude: 884.27.
elemental analysis results: c, 81.43; h, 4.78; n, 3.17; o, 3.62; p, 7.00; measurement values: c, 81.45; h, 4.77; n, 3.21; o, 3.65; p, 6.92.
Example 7
Synthesis of Compound P16
Figure BDA0002222601640000162
S2(1mmol), S6(1mmol) and S10(1mmol) were dissolved in toluene solvent under nitrogen protection, and Pd (PPh) was added3)4And refluxing for 6h at 120 ℃. After the reaction was completed, it was cooled to room temperature, and the crude product was collected. The crude product was purified by silica gel chromatography using a mixed solvent of n-hexane and chloroform (5:1) as an eluent to finally purify P16(0.68mmol, 68%) as a solid.
MALDI-TOF MS:C39H25N5Calculated m/z: 563.65, respectively; measurement values: 563.21. elemental analysis results: c, 83.10; h, 4.47; n, 12.43; measurement values: c, 83.06; h, 4.49; n, 12.45.
Example 8
Synthesis of Compound P17
Figure BDA0002222601640000171
S2(1mmol), S6(1mmol) and S11(1mmol) were dissolved in toluene solvent under nitrogen protection, and Pd (PPh) was added3)4And refluxing for 6h at 120 ℃. After the reaction was completed, it was cooled to room temperature, and the crude product was collected. The crude product was purified by silica gel chromatography using a mixed solvent of n-hexane and chloroform (5:1) as an eluent to finally purify P17(0.68mmol, 68%) as a solid.
MALDI-TOF MS:C39H25N5Calculated m/z: 563.65, respectively; measurement values: 563.21.
elemental analysis results: c, 83.10; h, 4.47; n, 12.43; measurement values: c, 83.06; h, 4.49; n, 12.45.
Example 9
Synthesis of Compound P22
Figure BDA0002222601640000181
S2(1mmol), S6(1mmol) and S25(1mmol) were dissolved in toluene solvent under nitrogen protection, and Pd (PPh) was added3)4And refluxing for 6h at 120 ℃. After the reaction was completed, it was cooled to room temperature, and the crude product was collected. The crude product was purified by silica gel chromatography using a mixed solvent of n-hexane and chloroform (5:1) as an eluent to finally purify P22(0.68mmol, 68%) as a solid.
MALDI-TOF MS:C36H25N2Calculated OP, m/z: 532.57, respectively; measurement values: 532.17.
elemental analysis results: c, 81.19; h, 4.73; n, 5.26; o, 3.00; p, 5.82; measurement values: c, 81.17; h, 4.70; n, 5.31; o, 3.03; p, 5.79.
Example 10
Synthesis of Compound P27
Figure BDA0002222601640000182
S12(1mmol) was dissolved in o-dichlorobenzene solvent under nitrogen protection, PPh3 was added, heated to reflux, and reacted for 8 h. After the reaction was completed, the reaction mixture was cooled to room temperature, and all the solvent was removed by distillation under the reduced pressure to collect a crude product. The crude product was purified by silica gel chromatography using a mixed solvent of n-hexane: chloroform (5:1) as an eluent to finally purify S13(0.92mmol, 92%) as a solid.
MALDI-TOF MS:C15H16N2Si, calculated m/z: 252.39, respectively; measurement values: 252.11.
s13(1mmol) and S6(2mmol) were dissolved in toluene solvent under nitrogen protection, and Pd (PPh) was added3)4At 120 ℃ CRefluxing for 6h under the condition. After the reaction was completed, it was cooled to room temperature, and the crude product was collected. The crude product was purified by silica gel chromatography using a mixed solvent of n-hexane: chloroform (5:1) as an eluent to finally purify S14(0.68mmol, 68%) as a solid.
MALDI-TOF MS:C27H24N2Si, calculated m/z: 404.58, respectively; measurement values: 404.17.
s14(1mmol) and NBS (3mmol) were dissolved in dichloromethane under nitrogen and stirred at room temperature for 12 h. After the reaction was completed, all the solvent was distilled off under reduced pressure, and the crude product was collected. The crude product was purified by silica gel chromatography using a mixed solvent of n-hexane and chloroform (5:1) as an eluent to finally purify S15(0.97mmol, 97%) as a solid.
MALDI-TOF MS:C24H15BrN2Calculated m/z: 411.29, respectively; measurement values: 410.04.
Figure BDA0002222601640000193
dissolving S15(1mmol) and S16(1mmol) in 1, 4-dioxane solvent under nitrogen protection, and adding Pd (PPh)3)4And refluxing for 6h at 120 ℃. After the reaction was completed, it was cooled to room temperature, and the crude product was collected. The crude product was purified by silica gel chromatography using a mixed solvent of n-hexane and chloroform (5:1) as an eluent to finally purify P27(0.68mmol, 68%) as a solid.
MALDI-TOF MS:C37H22N2O3S, calculated value of m/z: 574.65, mol.wt.: 574.65; measurement values: 574.14.
elemental analysis results: c, 77.33; h, 3.86; n, 4.87; o, 8.35; s, 5.58; measurement values: c, 77.30; h, 3.89; n, 4.86; o, 8.37; and S, 5.58.
Example 11
Synthesis of Compound P30
Figure BDA0002222601640000201
S15(1mmol) and S17(1mmol) were dissolved in dioxane solvent under nitrogen protection, and Pd (PPh) was added3)4And refluxing for 6h at 120 ℃. After the reaction was completed, it was cooled to room temperature, and the crude product was collected. The crude product was purified by silica gel chromatography using a mixed solvent of n-hexane and chloroform (5:1) as an eluent to finally purify P30(0.68mmol, 68%) as a solid.
MALDI-TOF MS:C42H27BN2Calculated m/z: 570.49, respectively; measurement values: 570.23.
elemental analysis results: c, 88.42; h, 4.77; b, 1.90; n, 4.91; measurement values: c, 88.40; h, 4.79; b, 1.91; and N, 4.90.
Example 12
Synthesis of Compound P31
Figure BDA0002222601640000202
S8(1mmol) and S22(2mmol) were dissolved in toluene solvent under nitrogen blanket, and Pd (PPh) was added3)4And refluxing for 6h at 120 ℃. After the reaction was completed, it was cooled to room temperature, and the crude product was collected. The crude product was purified by silica gel chromatography using a mixed solvent of n-hexane and chloroform (5:1) as an eluent to finally purify P31(0.88mmol, 88%) as a solid.
MALDI-TOF MS:C48H32N2O4S2Calculated m/z: 764.91, respectively; measurement values: 764.18.
elemental analysis results: c, 75.37; h, 4.22; n, 3.66; o, 8.37; s,8.38 measurement: c, 75.34; h, 4.25; n, 3.69; o, 8.39; s, 8.33.
Example 13
Synthesis of Compound P32
Figure BDA0002222601640000211
S8(1mmol) and S23(2mmol) were dissolved in toluene solvent under nitrogen blanket, and Pd (PPh) was added3)4And refluxing for 6h at 120 ℃. After the reaction was completed, it was cooled to room temperature, and the crude product was collected. The crude product was purified by silica gel chromatography using a mixed solvent of n-hexane and chloroform (5:1) as an eluent to finally purify P32(0.88mmol, 88%) as a solid.
MALDI-TOF MS:C72H46B2N2O2Calculated m/z: 992.77, respectively; measurement values: 992.37.
elemental analysis results: c, 87.11; h, 4.67; b, 2.18; n, 2.82; o,3.22 measurement: c, 87.14; h, 4.63; b, 2.15; n, 2.87; and O, 3.21.
Example 14
Synthesis of Compound P33
S8(1mmol) and S24(2mmol) were dissolved in toluene solvent under nitrogen blanket, and Pd (PPh) was added3)4And refluxing for 6h at 120 ℃. After the reaction was completed, it was cooled to room temperature, and the crude product was collected. The crude product was purified by silica gel chromatography using a mixed solvent of n-hexane and chloroform (5:1) as an eluent to finally purify P33(0.88mmol, 88%) as a solid.
MALDI-TOF MS:C54H26N8Calculated m/z: 786.84, respectively; measurement values: 786.23.
elemental analysis results: c, 82.43; h, 3.33; n,14.24 measurements: c, 82.47; h, 3.30; n, 14.23.
Parameter characterization of exemplary Compounds
Table 1 lists the main parameters of exemplary compounds P2, P13, P16, P17, P27, P30.
TABLE 1
Figure BDA0002222601640000222
Figure BDA0002222601640000231
Note that S1 represents the singlet energy level, T1 represents the triplet energy level, △ ESTRepresenting the difference between singlet and triplet energy levels, EgIndicating the HOMO-LUMO energy level difference.
As can be seen from Table 1, the compound of the present invention has high singlet and triplet energy levels, and the HOMO energy level and LUMO energy level are in proper positions, can be well matched with a general electron transport layer material or a hole transport layer material, and is suitable for being used as a host material of a light emitting layer.
The invention also provides a display panel which comprises an organic light-emitting device, wherein the organic light-emitting device comprises an anode, a cathode and a light-emitting layer positioned between the anode and the cathode which are oppositely arranged, and the light-emitting material of the light-emitting layer comprises one or more compounds disclosed by the invention.
In one embodiment of the display panel provided by the present invention, the light-emitting material of the light-emitting layer includes a host material and a guest material, the host material is selected from one or more compounds described in the present invention, and the guest material is selected from a fluorescent material, a thermally activated delayed fluorescent material, or a phosphorescent light-emitting material.
In one embodiment of the display panel provided by the present invention, the light emitting layer includes a host material and a guest material, the host material is selected from 2, 8-bis (diphenylphosphino) dibenzothiophene, 4' -bis (9-carbazole) biphenyl, 3' -bis (N-carbazolyl) -1,1' -biphenyl, 2, 8-bis (diphenylphosphinoxy) dibenzofuran, bis (4- (9H-carbazolyl-9-yl) phenyl) diphenylsilane, 9- (4-tert-butylphenyl) -3, 6-bis (triphenylsilyl) -9H-carbazole, bis (2-diphenylphosphino) diphenyl ether, 1, 3-bis [3, 5-bis (pyridin-3-yl) phenyl ] benzene, and a guest material, Any one or more of 4, 6-bis (3, 5-bis (3-pyridinylphenyl) -2-methylpyrimidine, 9- (3- (9H-carbazolyl-9-yl) phenyl) -9H-carbazole-3-cyano, 9-phenyl-9- [4- (triphenylsilyl) phenyl ] -9H-fluorene, 1,3, 5-tris (1-phenyl-1H-benzimidazol-2-yl) benzene, diphenyl [4- (triphenylsilyl) phenyl ] phosphine oxide, 4' -tris (carbazol-9-yl) triphenylamine, 2, 6-dicarbazole-1, 5-pyridine, polyvinylcarbazole and polyfluorene, the guest material is selected from one or more of the compounds described in the present invention.
According to one embodiment of the display panel of the present invention, the organic light emitting device further includes one or more of a hole injection layer, a hole transport layer, an electron blocking layer, a hole blocking layer, or an electron injection layer.
The hole injection material, hole transport material and electron blocking material may be selected from 2,2 '-dimethyl-N, N' -di-1-naphthyl-N, N '-diphenyl [1,1' -biphenyl]-4,4 '-diamine (. alpha. -NPD), 4' -tris (carbazol-9-yl) triphenylamine (TCTA), 1, 3-dicarbazolyl-9-ylbenzene (mCP), 4 '-bis (9-Carbazolyl) Biphenyl (CBP), 3' -bis (N-carbazolyl) -1,1 '-biphenyl (mCBP), 2,3,6,7,10, 11-hexacyano-1, 4,5,8,9, 12-Hexaazatriphenylene (HATCN), 4' -cyclohexylbis [ N, N-bis (4-methylphenyl) aniline (TAPC), N '-diphenyl-N, N' - (1-naphthyl) -1,1 '-biphenyl-4, 4' -diamine (. alpha. -NPB), N, N ' -bis (naphthalen-2-yl) -N, N ' -bis (phenyl) biphenyl-4, 4' -diamine (NPB), poly (3, 4-ethylenedioxythiophene) -polystyrenesulfonic acid (PEDOT: PSS), Polyvinylcarbazole (PVK), 9-phenyl-3, 9-bicarbazole (CCP), molybdenum trioxide (MoO)3) And the like, but not limited to the above materials.
The hole blocking material, the electron transporting material, and the electron injecting material may be selected from 2, 8-bis (diphenylphosphino) dibenzothiophene (PPT), TSPO1, 1,3, 5-tris (1-phenyl-1H-benzimidazol-2-yl) benzene (TPBi), 2, 8-bis (diphenylphosphinoxy) dibenzofuran (PPF), bis (2-diphenylphosphino) diphenyl ether (DPEPO), lithium fluoride (LiF), 4, 6-bis (3, 5-bis (3-pyridyl) ylphenyl) -2-methylpyrimidine (B3PYMPM), 4, 7-diphenyl-1, 10-phenanthroline (Bphen), 1,3, 5-tris [ (3-pyridyl) -3-phenyl ] phenanthroline (Bphen)]Benzene (TmPyBP), tris [2,4, 6-trimethyl-3- (3-pyridyl) phenyl]Borane (3TPYMB), 1, 3-bis (3, 5-bipyridin-3-ylphenyl) benzene (B3PYPB), 1, 3-bis [3, 5-bis (pyridin-3-yl) phenyl]Benzene (BMPYPHB), 2,4, 6-tris (biphenyl-3-yl) -1,3, 5-triazine (T2T), diphenylbis [4- (pyridin-3-yl) phenyl]Silane (DPPS), cesium carbonate (Cs)2O3) Bis (2-methyl-8-hydroxyquinoline-N1, O8) - (1,1' -biphenyl-4-hydroxy) aluminum (BALq),8-Hydroxyquinoline-lithium (Liq) and tris (8-Hydroxyquinoline) aluminum (Alq)3) And the like, but not limited to the above materials.
In the display panel provided by the present invention, the anode material of the organic light emitting device may be selected from metals such as copper, gold, silver, iron, chromium, nickel, manganese, palladium, platinum, and the like, and alloys thereof. The anode material may also be selected from metal oxides such as indium oxide, zinc oxide, Indium Tin Oxide (ITO), Indium Zinc Oxide (IZO), and the like; the anode material may also be selected from conductive polymers such as polyaniline, polypyrrole, poly (3-methylthiophene), and the like. In addition, the anode material may be selected from materials that facilitate hole injection in addition to the listed anode materials and combinations thereof, including known materials suitable for use as anodes.
In the display panel provided by the present invention, the cathode material of the organic light emitting device may be selected from metals such as aluminum, magnesium, silver, indium, tin, titanium, and the like, and alloys thereof. The cathode material may also be selected from multi-layered metallic materials such as LiF/Al, LiO2/Al、BaF2Al, etc. In addition to the cathode materials listed above, the cathode materials can also be materials that facilitate electron injection and combinations thereof, including materials known to be suitable as cathodes.
The organic light emitting device may be fabricated according to a method well known in the art and will not be described in detail herein. In the present invention, the organic light emitting device can be fabricated by: an anode is formed on a transparent or opaque smooth substrate, an organic thin layer is formed on the anode, and a cathode is formed on the organic thin layer. The organic thin layer can be formed by a known film formation method such as evaporation, sputtering, spin coating, dipping, ion plating, or the like.
In one embodiment of the display panel according to the present invention, the structure of an Organic Light Emitting Device (OLED) is as shown in fig. 2. Wherein 1 is a substrate (substrate) made of glass or other suitable materials (such as plastics); 2 is a transparent anode such as ITO or IGZO; 3 is an organic film layer (including a luminescent layer); and 4, metal cathodes which jointly form a complete OLED device.
The following exemplary organic light emitting device examples are provided to illustrate the practical use of the compounds of the present invention as host materials for the light emitting layer of an organic light emitting device in an organic light emitting display panel.
Device example 1
The anode substrate having an ITO thin film with a film thickness of 100nm was ultrasonically cleaned with distilled water, acetone, and isopropanol, placed in an oven for drying, surface-treated by UV for 30 minutes, and then moved to a vacuum evaporation chamber. Under vacuum degree of 2X 10-6Pa, each layer of thin film was evaporated, 5nm thick HATCN was evaporated to form a hole injection layer, 40nm thick N, N ' -diphenyl-N, N ' - (1-naphthyl) -1,1' -biphenyl-4, 4' -diamine (NPB) was evaporated, and 10nm thick 4,4',4 ″ -tris (carbazol-9-yl) triphenylamine (TCTA) was evaporated to form a Hole Transport Layer (HTL). On the hole transport layer, the object compound P2 of the present invention was used as a host material for a light-emitting layer, Ir (ppy)3As a guest material of the light-emitting layer, the dopant material and the host material were simultaneously evaporated to form a light-emitting layer having a thickness of 30 nm. Then diphenyl [4- (triphenylsilyl) phenyl ] is evaporated on the luminescent layer]Phosphine oxide (TSPO1) formed a Hole Blocking Layer (HBL) 5nm thick. Evaporating 4, 7-diphenyl-1, 10-phenanthroline (Bphen) on the hole blocking layer to form an Electron Transport Layer (ETL) of 30 nm. LiF with the thickness of 2.5nm and Al with the thickness of 100nm are sequentially evaporated on the electron transport layer to be used as an Electron Injection Layer (EIL) and a cathode, so that the organic light-emitting display device is manufactured.
The organic electroluminescent device can also be prepared by adopting a solution processing method.
Figure BDA0002222601640000261
Device example 2
The difference from device example 1 was that compound P2 was replaced with compound P13, and the other preparation steps were the same as those in device example 1.
Device example 3
The difference from device example 1 was that compound P2 was replaced with compound P16, and the other preparation steps were the same as those in device example 1.
Device example 4
The difference from device example 1 was that compound P2 was replaced with compound P17, and the other preparation steps were the same as those in device example 1.
Device example 5
The difference from device example 1 was that compound P2 was replaced with compound P27, and the other preparation steps were the same as those in device example 1.
Device example 6
The difference from device example 1 was that compound P2 was replaced with compound P30, and the other preparation steps were the same as those in device example 1.
Comparative device example 1
The difference from device example 1 is that compound P2 was replaced by compound CBP and the other preparation steps were the same as the corresponding steps in device example 1.
TABLE 2 device Performance characterization
Figure BDA0002222601640000271
As can be seen from table 2, EQE of the organic light emitting device using P2, P13, P16, P17, P27, P30 as host materials, compared to comparative device 1 using the classical blue light emitting material CBP as phosphorescent host material(max)The organic electroluminescent material is obviously higher than a contrast device, and the excellent hole and electron transport efficiency of the P2, P13, P16, P17, P27 and P30 bipolar host materials is mainly benefited, so that the driving voltage of the device is reduced, and the efficiency of the device is improved.
Although the present application has been described with reference to preferred embodiments, it is not intended to limit the scope of the claims, and many possible variations and modifications may be made by one skilled in the art without departing from the spirit of the application.

Claims (22)

1. A compound having the structure shown in formula (1):
Figure FDA0002222601630000011
A1and A2Represents an electron-accepting group, and A1And A2Each independently selected from hydrogen atom, carbonyl group-containing substituent, imide substituent, phosphorus-oxygen-containing substituent, fluorine-containing substituent, sulfone substituent, aryl boron substituent and cyanogen-containing substituent;
L1and L2Each independently selected from the group consisting of a single bond, phenylene, thienylene, naphthylene, anthracenylene, phenanthrenylene, pyrenylene;
Ar1and Ar2Each independently selected from hydrogen atom, phenyl, thienyl, naphthyl, anthryl, phenanthryl, pyrenyl, carbonyl-containing substituent, imide substituent, phosphorus-oxygen-containing substituent, fluorine-containing substituent, sulfone substituent, aryl boron substituent and cyanogen-containing substituent.
2. The compound of claim 1, wherein L is1And L2Selected from phenylene.
3. The compound of claim 2, wherein Ar is Ar1And Ar2Selected from hydrogen atoms.
4. The compound of claim 1, wherein L is1And L2Is phenylene, A1And A2Is a hydrogen atom.
5. The compound of claim 1, wherein L is1And L2Selected from the same group, A1And A2Are selected from the same group, and Ar1And Ar2Selected from the same group.
6. The compound of claim 4, wherein Ar is Ar1And Ar2Each independently selected from carbonyl group-containing substituentsThe substituent group comprises a group, an imide substituent group, a phosphorus-oxygen-containing substituent group, a fluorine-containing substituent group, a sulfone substituent group, an aryl boron substituent group and a cyanogen-containing substituent group.
7. The compound of claim 1, wherein the compound has any one of the structures represented by formula (2), formula (3), and formula (4):
Figure FDA0002222601630000021
wherein Ar is1、Ar2And Ar3Are respectively selected from one of phosphorus-oxygen-containing substituent groups, sulfone substituent groups and aryl boron substituent groups.
8. The compound of any one of claims 1 to 7, wherein said carbonyl-containing substituent is selected from one of the following groups:
Figure FDA0002222601630000022
wherein # represents a position capable of linking to formula (1), formula (2), formula (3) or formula (4), and R represents a C1-C20 alkyl group, a C1-C20 alkoxy group, a C2-C20 alkenyl group, a C2-C20 alkynyl group, a C4-C8 cycloalkyl group, a C6-C40 aryl group, a C4-C40 heteroaryl group.
9. A compound according to any one of claims 1 to 7, characterised in that the imide-based substituent is selected from one of the following groups:
Figure FDA0002222601630000031
wherein # represents a position capable of linking to formula (1), formula (2), formula (3) or formula (4), and R represents a C1-C20 alkyl group, a C1-C20 alkoxy group, a C2-C20 alkenyl group, a C2-C20 alkynyl group, a C4-C8 cycloalkyl group, a C6-C40 aryl group, a C4-C40 heteroaryl group.
10. The compound of any one of claims 1 to 7, wherein the phosphorus-oxygen-containing substituent is selected from one of the following groups:
Figure FDA0002222601630000032
x is selected from O, S, -BR41、-C(R41)2、-Si(R41)2and-NR41Any one of the above;
R30、R31、R32、R33、R34、R35、R36、R37、R38、R39、R40、R41each independently selected from any one of a hydrogen atom, a substituted or unsubstituted C1-C20 alkyl group, a substituted or unsubstituted C3-C20 cycloalkyl group, a substituted or unsubstituted C1-C20 alkoxy group, a substituted or unsubstituted C3-C20 heterocyclic group, a substituted or unsubstituted C6-C40 aryl group and a substituted or unsubstituted C2-C40 heteroaryl group;
# represents a position at which the compound represented by formula (1), formula (2), formula (3) or formula (4) can be linked.
11. The compound of any one of claims 1 to 7, wherein said fluorine-containing substituent is selected from one of the following groups:
Figure FDA0002222601630000041
# represents a position at which the compound represented by formula (1), formula (2), formula (3) or formula (4) can be linked.
12. A compound according to any one of claims 1 to 7, wherein the sulfone substituent is selected from one of the following groups:
Figure FDA0002222601630000042
# represents a position at which the compound represented by formula (1), formula (2), formula (3) or formula (4) can be linked.
13. A compound according to any one of claims 1 to 7, characterised in that the arylboron-based substituent is selected from one of the following groups:
Figure FDA0002222601630000043
R15-R23each independently selected from alkyl, alkoxy, phenyl, aryl or heteroaryl; x1Selected from the group consisting of boron, oxygen, sulfur, nitrogen, when X1When it is an oxygen atom or a sulfur atom, R23Is absent;
# represents the position to which formula (1), formula (2), formula (3) or formula (4) is linked.
14. A compound according to any one of claims 1 to 7, characterised in that the arylboron-based substituent is selected from one of the following groups:
Figure FDA0002222601630000051
# represents a position at which the compound represented by formula (1), formula (2), formula (3) or formula (4) can be linked.
15. The compound of any one of claims 1 to 7, wherein the cyano-containing substituent is selected from one of the following groups:
Figure FDA0002222601630000052
wherein # represents a position at which formula (1), (2), (3) or (4) can be linked.
16. The compound of claim 1, wherein the compound is selected from the group consisting of:
Figure FDA0002222601630000061
Figure FDA0002222601630000071
17. the compound of any one of claims 1 to 16, wherein the energy level difference Δ Ε between the lowest singlet energy level S1 and the lowest triplet energy level T1 is the compoundST=ES1-ET1≦0.30eV。
18. A display panel comprising an organic light emitting device, wherein the organic light emitting device comprises an anode and a cathode oppositely arranged, and a light emitting layer between the anode and the cathode, wherein a light emitting material of the light emitting layer comprises one or more compounds of any one of claims 1 to 17.
19. The display panel according to claim 18, wherein the light-emitting material of the light-emitting layer comprises a host material and a guest material, and the guest material is one or more compounds according to any one of claims 1 to 17.
20. The display panel according to claim 18, wherein the light-emitting material of the light-emitting layer comprises a host material and a guest material, and the host material is one or more compounds according to any one of claims 1 to 17.
21. The display panel according to any one of claims 18 to 20, wherein the organic light-emitting device further comprises one or more of a hole injection layer, a hole transport layer, an electron blocking layer, a hole blocking layer, or an electron injection layer.
22. A display device comprising the display panel of any one of claims 18 to 21.
CN201910939930.6A 2019-09-30 2019-09-30 Compound, display panel and display device Pending CN110669051A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910939930.6A CN110669051A (en) 2019-09-30 2019-09-30 Compound, display panel and display device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910939930.6A CN110669051A (en) 2019-09-30 2019-09-30 Compound, display panel and display device

Publications (1)

Publication Number Publication Date
CN110669051A true CN110669051A (en) 2020-01-10

Family

ID=69080433

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910939930.6A Pending CN110669051A (en) 2019-09-30 2019-09-30 Compound, display panel and display device

Country Status (1)

Country Link
CN (1) CN110669051A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115141189A (en) * 2021-03-31 2022-10-04 上海和辉光电股份有限公司 Organic electroluminescent compound and application thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150022521A (en) * 2013-08-23 2015-03-04 제일모직주식회사 Compound, organic optoelectric device and display device
KR20150115495A (en) * 2014-04-04 2015-10-14 (주)피엔에이치테크 Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR20150121626A (en) * 2014-04-21 2015-10-29 (주)피엔에이치테크 Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR20150137265A (en) * 2014-05-29 2015-12-09 (주)피엔에이치테크 An electroluminescent compound and an electroluminescent device comprising the same
KR20160036162A (en) * 2014-09-24 2016-04-04 에스에프씨 주식회사 An organoelectro luminescent compounds and organoelectro luminescent device using the same
KR20170126400A (en) * 2016-05-09 2017-11-17 덕산네오룩스 주식회사 Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof
CN108511613A (en) * 2017-02-28 2018-09-07 三星电子株式会社 Organic luminescent device

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150022521A (en) * 2013-08-23 2015-03-04 제일모직주식회사 Compound, organic optoelectric device and display device
KR20150115495A (en) * 2014-04-04 2015-10-14 (주)피엔에이치테크 Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR20150121626A (en) * 2014-04-21 2015-10-29 (주)피엔에이치테크 Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR20150137265A (en) * 2014-05-29 2015-12-09 (주)피엔에이치테크 An electroluminescent compound and an electroluminescent device comprising the same
KR20160036162A (en) * 2014-09-24 2016-04-04 에스에프씨 주식회사 An organoelectro luminescent compounds and organoelectro luminescent device using the same
KR20170126400A (en) * 2016-05-09 2017-11-17 덕산네오룩스 주식회사 Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof
CN108511613A (en) * 2017-02-28 2018-09-07 三星电子株式会社 Organic luminescent device

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115141189A (en) * 2021-03-31 2022-10-04 上海和辉光电股份有限公司 Organic electroluminescent compound and application thereof

Similar Documents

Publication Publication Date Title
CN108864068B (en) Compound and organic light-emitting display device
US9732036B2 (en) Compound having carbazole ring structure, and organic electroluminescent device
CN108997400B (en) Aromatic compound and organic light-emitting display device
US20170271595A1 (en) Compound having substituted triphenylene ring structure, and organic electroluminescent device
CN107129471B (en) Organic compound, organic photoelectric device and display device
CN112661714B (en) Heterocyclic compound and organic electroluminescent device containing same
JP2018524276A (en) Compound for organic optoelectronic device, organic optoelectronic device, and display device
CN108727405B (en) Aromatic heterocyclic compound and organic light-emitting display device
US20200381631A1 (en) Compound, display panel and display apparatus
KR101982749B1 (en) Chemical and Organic Electronic Element using the same, Electronic Device thereof
CN110642842B (en) Compound, display panel and display device
CN110003258A (en) Compound, display panel and display device
CN111423460B (en) Compound, display panel and display device
CN111808127B (en) Compound, display panel and display device
CN111170928B (en) Compound, display panel and display device
CN111848414B (en) Arylamine compound and organic electroluminescent device comprising same
CN110698504B (en) Boron heterocyclic compound, display panel, and display device
CN113801117B (en) Organic compound and electroluminescent application thereof
CN110669051A (en) Compound, display panel and display device
KR102518765B1 (en) Novel compound and organic light-emitting diode using them
CN110746413B (en) Compound, display panel and display device
CN110016018B (en) Compound, display panel and display device
CN111533762A (en) Boron heterocyclic compound, display panel, and display device
CN114163447B (en) Organic compound and electroluminescent application thereof
CN111848642B (en) Compound, display panel and display device

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20200110

RJ01 Rejection of invention patent application after publication